Logo image of ALNSE.PA

NSE (ALNSE.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALNSE - FR0004065639 - Common Stock

41 EUR
0 (0%)
Last: 12/3/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, ALNSE scores 5 out of 10 in our fundamental rating. ALNSE was compared to 48 industry peers in the Aerospace & Defense industry. While ALNSE has a great health rating, there are worries on its profitability. ALNSE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALNSE was profitable.
In the past year ALNSE had a positive cash flow from operations.
Each year in the past 5 years ALNSE has been profitable.
ALNSE had a positive operating cash flow in 4 of the past 5 years.
ALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

The Return On Assets of ALNSE (2.11%) is worse than 68.75% of its industry peers.
ALNSE has a worse Return On Equity (4.58%) than 72.92% of its industry peers.
With a Return On Invested Capital value of 7.73%, ALNSE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALNSE is in line with the industry average of 9.50%.
Industry RankSector Rank
ROA 2.11%
ROE 4.58%
ROIC 7.73%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ALNSE.PA Yearly ROA, ROE, ROICALNSE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1.3 Margins

ALNSE has a worse Profit Margin (2.09%) than 70.83% of its industry peers.
ALNSE's Profit Margin has declined in the last couple of years.
ALNSE's Operating Margin of 5.38% is on the low side compared to the rest of the industry. ALNSE is outperformed by 77.08% of its industry peers.
ALNSE's Operating Margin has declined in the last couple of years.
ALNSE has a better Gross Margin (45.65%) than 70.83% of its industry peers.
ALNSE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.38%
PM (TTM) 2.09%
GM 45.65%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
ALNSE.PA Yearly Profit, Operating, Gross MarginsALNSE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALNSE is creating some value.
Compared to 1 year ago, ALNSE has about the same amount of shares outstanding.
ALNSE has more shares outstanding than it did 5 years ago.
ALNSE has a better debt/assets ratio than last year.
ALNSE.PA Yearly Shares OutstandingALNSE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALNSE.PA Yearly Total Debt VS Total AssetsALNSE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 3.71 indicates that ALNSE is not in any danger for bankruptcy at the moment.
ALNSE's Altman-Z score of 3.71 is fine compared to the rest of the industry. ALNSE outperforms 77.08% of its industry peers.
ALNSE has a debt to FCF ratio of 1.73. This is a very positive value and a sign of high solvency as it would only need 1.73 years to pay back of all of its debts.
ALNSE has a Debt to FCF ratio of 1.73. This is amongst the best in the industry. ALNSE outperforms 81.25% of its industry peers.
ALNSE has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.10, ALNSE belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.73
Altman-Z 3.71
ROIC/WACC0.99
WACC7.83%
ALNSE.PA Yearly LT Debt VS Equity VS FCFALNSE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ALNSE has a Current Ratio of 1.70. This is a normal value and indicates that ALNSE is financially healthy and should not expect problems in meeting its short term obligations.
ALNSE has a Current ratio of 1.70. This is in the better half of the industry: ALNSE outperforms 79.17% of its industry peers.
ALNSE has a Quick Ratio of 1.33. This is a normal value and indicates that ALNSE is financially healthy and should not expect problems in meeting its short term obligations.
ALNSE has a Quick ratio of 1.33. This is amongst the best in the industry. ALNSE outperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.33
ALNSE.PA Yearly Current Assets VS Current LiabilitesALNSE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

The earnings per share for ALNSE have decreased strongly by -58.66% in the last year.
The Earnings Per Share has been decreasing by -9.31% on average over the past years.
ALNSE shows a small growth in Revenue. In the last year, the Revenue has grown by 3.20%.
ALNSE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.37% yearly.
EPS 1Y (TTM)-58.66%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-57.73%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%-6.51%

3.2 Future

ALNSE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.88% yearly.
The Revenue is expected to grow by 32.29% on average over the next years. This is a very strong growth
EPS Next Y36.08%
EPS Next 2Y46.2%
EPS Next 3Y35.88%
EPS Next 5YN/A
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3Y32.29%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALNSE.PA Yearly Revenue VS EstimatesALNSE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALNSE.PA Yearly EPS VS EstimatesALNSE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

ALNSE is valuated quite expensively with a Price/Earnings ratio of 63.08.
Based on the Price/Earnings ratio, ALNSE is valued a bit more expensive than 66.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALNSE to the average of the S&P500 Index (26.37), we can say ALNSE is valued expensively.
A Price/Forward Earnings ratio of 12.80 indicates a correct valuation of ALNSE.
Based on the Price/Forward Earnings ratio, ALNSE is valued cheaper than 95.83% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.20, ALNSE is valued rather cheaply.
Industry RankSector Rank
PE 63.08
Fwd PE 12.8
ALNSE.PA Price Earnings VS Forward Price EarningsALNSE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

79.17% of the companies in the same industry are more expensive than ALNSE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALNSE is valued a bit cheaper than 60.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 36.46
EV/EBITDA 13.96
ALNSE.PA Per share dataALNSE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ALNSE's earnings are expected to grow with 35.88% in the coming years.
PEG (NY)1.75
PEG (5Y)N/A
EPS Next 2Y46.2%
EPS Next 3Y35.88%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.67%, ALNSE is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.21, ALNSE has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, ALNSE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.67%

5.2 History

On average, the dividend of ALNSE grows each year by 22.60%, which is quite nice.
Dividend Growth(5Y)22.6%
Div Incr Years2
Div Non Decr Years5
ALNSE.PA Yearly Dividends per shareALNSE.PA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

ALNSE pays out 41.18% of its income as dividend. This is a bit on the high side, but may be sustainable.
ALNSE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.18%
EPS Next 2Y46.2%
EPS Next 3Y35.88%
ALNSE.PA Yearly Income VS Free CF VS DividendALNSE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M
ALNSE.PA Dividend Payout.ALNSE.PA Dividend Payout, showing the Payout Ratio.ALNSE.PA Dividend Payout.PayoutRetained Earnings

NSE

EPA:ALNSE (12/3/2025, 7:00:00 PM)

41

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-23 2025-07-23
Earnings (Next)N/A N/A
Inst Owners21.02%
Inst Owner ChangeN/A
Ins Owners64.28%
Ins Owner ChangeN/A
Market Cap138.58M
Revenue(TTM)99.97M
Net Income(TTM)2.09M
Analysts86.67
Price Target65.28 (59.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.67%
Yearly Dividend0.25
Dividend Growth(5Y)22.6%
DP41.18%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)28%
PT rev (3m)28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)8.79%
EPS NY rev (3m)8.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 63.08
Fwd PE 12.8
P/S 1.39
P/FCF 36.46
P/OCF 18.18
P/B 3.03
P/tB 3.43
EV/EBITDA 13.96
EPS(TTM)0.65
EY1.59%
EPS(NY)3.2
Fwd EY7.81%
FCF(TTM)1.12
FCFY2.74%
OCF(TTM)2.26
OCFY5.5%
SpS29.58
BVpS13.52
TBVpS11.96
PEG (NY)1.75
PEG (5Y)N/A
Graham Number14.06
Profitability
Industry RankSector Rank
ROA 2.11%
ROE 4.58%
ROCE 10.31%
ROIC 7.73%
ROICexc 10.37%
ROICexgc 12%
OM 5.38%
PM (TTM) 2.09%
GM 45.65%
FCFM 3.8%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ROICexc(3y)11.65%
ROICexc(5y)13.8%
ROICexgc(3y)13.37%
ROICexgc(5y)15.81%
ROCE(3y)12.32%
ROCE(5y)14.64%
ROICexgc growth 3Y-2.2%
ROICexgc growth 5Y-7.13%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y-7.79%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.73
Debt/EBITDA 0.52
Cap/Depr 108.86%
Cap/Sales 3.82%
Interest Coverage 29.25
Cash Conversion 85.72%
Profit Quality 181.61%
Current Ratio 1.7
Quick Ratio 1.33
Altman-Z 3.71
F-Score5
WACC7.83%
ROIC/WACC0.99
Cap/Depr(3y)97.38%
Cap/Depr(5y)100.98%
Cap/Sales(3y)3.76%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.66%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-57.73%
EPS Next Y36.08%
EPS Next 2Y46.2%
EPS Next 3Y35.88%
EPS Next 5YN/A
Revenue 1Y (TTM)3.2%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%-6.51%
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3Y32.29%
Revenue Next 5YN/A
EBIT growth 1Y-23.13%
EBIT growth 3Y3.84%
EBIT growth 5Y-6.03%
EBIT Next Year110.2%
EBIT Next 3Y55.39%
EBIT Next 5YN/A
FCF growth 1Y26.15%
FCF growth 3Y-2.62%
FCF growth 5Y6.82%
OCF growth 1Y22.28%
OCF growth 3Y-2.36%
OCF growth 5Y8.53%

NSE / ALNSE.PA FAQ

What is the fundamental rating for ALNSE stock?

ChartMill assigns a fundamental rating of 5 / 10 to ALNSE.PA.


What is the valuation status of NSE (ALNSE.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to NSE (ALNSE.PA). This can be considered as Fairly Valued.


How profitable is NSE (ALNSE.PA) stock?

NSE (ALNSE.PA) has a profitability rating of 3 / 10.


What are the PE and PB ratios of NSE (ALNSE.PA) stock?

The Price/Earnings (PE) ratio for NSE (ALNSE.PA) is 63.08 and the Price/Book (PB) ratio is 3.03.


Can you provide the expected EPS growth for ALNSE stock?

The Earnings per Share (EPS) of NSE (ALNSE.PA) is expected to grow by 36.08% in the next year.